METHOD OF TREATING PATIENTS SUFFERING FROM COMPLICATED FORMS OF ERYSIPELAS Russian patent published in 2015 - IPC A61K31/713 A61K33/24 A61P17/00 

FIELD: medicine.

SUBSTANCE: from the 2^nd-3^rd day and 10 days on after admission to hospital, Derinat is administered intramuscularly as an immunomodulatory preparation for 1-2 minutes in a dose of 1.5% (75 mg) of the solution every 45 hours (as directed in the instructions). On the 3^rd-4^th postoperative day, at the stage of granulation formation, the wound is coated by uniform layers of an aquacomplex of glycerosolvate titanium 0.3 g per 1 square dm of the wound as local daily applications for 10-20 days.

EFFECT: higher clinical effectiveness and reduced length of treatment and side reactions accompanying the administration of immunomodulatory agents, enabled reduction of complications of the erysipelas, considerably reduced length of intoxication manifestations, accelerated regression of local manifestations, and stimulated wound regeneration.

2 ex